Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
Showing 26 - 50 of >10,000
Osteoarthritis Trial in Canada (ATB-346 low dose, Placebo, ATB-346 mid-dose)
Completed
- Osteoarthritis
- ATB-346 low dose
- +3 more
-
Mission, British Columbia, Canada
- +34 more
Jul 20, 2022
CVD Risk Profile in Children With HCM
Recruiting
- Hypertrophic Cardiomyopathy
-
Edmonton, Alberta, Canada
- +9 more
Aug 18, 2022
Elbow Fracture, Elbow Injury, Elbow Dislocation Trial in Canada, United States (Lactose Placebo, Ketotifen Fumarate 2mg,
Recruiting
- Elbow Fracture
- +2 more
- Lactose Placebo
- +2 more
-
Baltimore, Maryland
- +16 more
Dec 8, 2022
Shoulder Arthritis, Anesthesia, Local, Local Infiltration Trial in London (100 mL of 0.9% normal saline (57ml), 0.5% ropivacaine
Not yet recruiting
- Shoulder Arthritis
- +2 more
- 100 mL of 0.9% normal saline (57ml), 0.5% ropivacaine (40 ml), 10 mg morphine (10 mg/ml), 0.1 mg of epinephrine (0.1 mg/ml), and 30 mg of ketorolac (30 mg/ml)
-
London, Ontario, CanadaSt. Josephs Healthcare London
Jun 14, 2023
Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0) Trial in Canada (Whole-body FDG PET-CT
Active, not recruiting
- Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)
- Stage IIb Breast Cancer (T3N0)
- Whole-body FDG PET-CT alone
-
Hamilton, Ontario, Canada
- +5 more
Apr 19, 2022
Cancer, Tumour, Surgery Trial in Canada, United States (Tranexamic acid (TXA), Normal saline)
Active, not recruiting
- Cancer
- +2 more
- Tranexamic acid (TXA)
- Normal saline
-
Rochester, Minnesota
- +10 more
Oct 25, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
Hyperactive Delirium, Delirium of Mixed Origin Trial (Dexmedetomidine Hydrochloride)
Recruiting
- Hyperactive Delirium
- Delirium of Mixed Origin
- Dexmedetomidine Hydrochloride
-
Calgary, Alberta, Canada
- +3 more
Dec 16, 2022
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
Recruiting
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
-
Miami, Florida
- +8 more
Jan 24, 2023
Pancreatic Adenocarcinoma Trial in Canada (Gemcitabine, Nab-paclitaxel, Durvalumab)
Active, not recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- +3 more
-
Calgary, Alberta, Canada
- +26 more
May 9, 2022
Myocardial Infarction, STEMI Trial in Canada (SMART AMI APPLICATION)
Enrolling by invitation
- Myocardial Infarction
- STEMI
- SMART AMI APPLICATION
-
Brantford, Ontario, Canada
- +16 more
Mar 11, 2022
Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)
Active, not recruiting
- Breast Cancer
- Breast Neoplasm
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jan 17, 2023
Metastatic Tumors Trial in Worldwide (radiation, drug, other)
Recruiting
- Metastatic Tumors
- Palliative Radiation
- +5 more
-
Melbourne, Victoria, Australia
- +13 more
Oct 13, 2022
Acute Respiratory Distress Syndrome, Hypoxemic Respiratory Failure, ARDS, Human Trial in Canada (TheraPPP)
Recruiting
- Acute Respiratory Distress Syndrome
- +2 more
- TheraPPP
-
Calgary, Alberta, Canada
- +16 more
Jul 21, 2022
Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))
Suspended
- Gastroenteropancreatic Neuroendocrine Tumor
- Lutathera
- +4 more
-
Stanford, CaliforniaStanford Cancer Institute Palo Alto
Sep 21, 2022
Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )
Active, not recruiting
- Vasovagal Syncope
- midodrine hydrochloride
- matching placebo
-
Minneapolis, Minnesota
- +16 more
Nov 1, 2022
Patent Ductus Arteriosus After Premature Birth Trial in Hamilton, Toronto, Dublin (Acetaminophen Injection, Ibuprofen 20 mg/mL
Recruiting
- Patent Ductus Arteriosus After Premature Birth
- Acetaminophen Injection
- +2 more
-
Hamilton, Ontario, Canada
- +3 more
Jan 30, 2023
Glabellar Frown Lines Trial in Canada, United States (Botulinum Toxins, Type A, Placebos)
Completed
- Glabellar Frown Lines
- Botulinum Toxins, Type A
- Placebos
-
Encinitas, California
- +13 more
Jun 29, 2022
Kidney Stone Trial in Canada (LithoVue Elite)
Not yet recruiting
- Kidney Stone
- LithoVue Elite
-
Vancouver, British Columbia, Canada
- +5 more
Aug 1, 2022
Multiple Sclerosis Trial in Calgary, Edmonton, Kingston (MS INFoRm, Usual Care Control Group)
Completed
- Multiple Sclerosis
- MS INFoRm
- Usual Care Control Group
-
Calgary, Alberta, Canada
- +2 more
Apr 18, 2022
The RAPID COVID-19 TRIAGE Algorithm
Active, not recruiting
- COVID-19
- Spartan Cube Point-of Care Covid-19 test
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Jan 12, 2023
Chin Augmentation and Correction Trial in Canada (Hyaluronic Acid)
Completed
- Chin Augmentation and Correction
- Hyaluronic Acid
-
Calgary, Alberta, Canada
- +8 more
Jun 21, 2022
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed
Recruiting
- Relapsed Non Hodgkin Lymphoma
- +2 more
- autologous CD19-directed chimeric antigen receptor (CAR) T-cells
-
Calgary, Alberta, Canada
- +5 more
Jul 18, 2022